Sana Biotechnology Inc reports results for the quarter ended in June - Earnings Summary

Sana Biotechnology

05/08/2021 03:04

* Sana Biotechnology Inc  SANA.OQ  reported a quarterly adjusted
loss of 32 cents​​ per share for the quarter ended in June. The
mean expectation of three analysts for the quarter was for a
loss of 45 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Sana Biotechnology Inc's reported EPS for the quarter was 10
cents​.
* The mean earnings estimate of analysts had fallen by
about 26.8% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Sana Biotechnology Inc shares had fallen by 10.4% this
quarter.
* The company reported quarterly net income of $18.68 million.
* Wall Street's median 12-month price target for Sana
Biotechnology Inc is $40.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 5 at 02:04 a.m.  ​All
figures in US dollars unless otherwise stated